Abstract
Sustained Efficacy and Safety in Adult and Pediatric Patients with Transfusion-Dependent β-Thalassemia up to 9 Years Post Treatment with Betibeglogene Autotemcel (Beti-cel)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have